Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis
Author(s) -
Arseima Y. Del Valle-Pinero,
LeeAnne B. Sherwin,
Ethan M. Anderson,
Robert M. Caudle,
Wendy A. Henderson
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i1.155
Subject(s) - vasoactive intestinal peptide , colitis , myeloperoxidase , medicine , irritable bowel syndrome , endocrinology , inflammation , inflammatory bowel disease , immunology , gastroenterology , neuropeptide , receptor , disease
To investigate the vasoactive intestinal peptides (VIP) expression in irritable bowel syndrome (IBS) and trinitrobenzene sulfonic acid (TNBS) induced colitis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom